Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 13 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Thyroid Diseases 2 Prostatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thrombosis 1 Venous Thromboembolism 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thrombosis 1 Testicular Neoplasms 1

Interventions

Temozolomide 264 Radiotherapy 119 Bevacizumab 105 Magnetic Resonance Spectroscopy 59 Radiation 47 pembrolizumab 30 Irinotecan 28 Surgical Procedures, Operative 23 Lomustine 21 Specimen Handling 19 Nivolumab 19 Radiosurgery 18 Carmustine 18 Aminolevulinic Acid 16 Erlotinib Hydrochloride 15 Drug Therapy 15 Blood Specimen Collection 14 Radiotherapy, Intensity-Modulated 13 O(6)-benzylguanine 13 Chemotherapy, Adjuvant 13 Carboplatin 13 Filgrastim 11 Cyclophosphamide 11 sargramostim 10 poly ICLC 10 atezolizumab 10 Thalidomide 10 Etoposide 10 Ipilimumab 9 Everolimus 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioblastoma × Data Collection × Clear all

NCT07499141 2026-03-30

UFGAG

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡